热门资讯> 正文
RNZ、QBTS和WAVD均为上市前涨幅股
2024-05-10 21:02
- Gainers: Novavax (NVAX) +108% surges as Sanofi COVID vaccine deal boosts outlook.
- Aethlon Medical (AEMD) +42% Results From an In Vitro Binding Study of Its Hemopurifier in Removing Extracellular Vesicles From Cancer Patient Plasma
- AEye (LIDR) +38% announces partnership with automotive electronics and vision solutions provider LITEON.
- Sensus Healthcare (SRTS) +32% Q1 earnings call release
- ITeos Therapeutics (ITOS) +38% Reports First Quarter 2024 Financial Results and Provides Business Updates.
- WiSA Technologies (WISA) +25% Announces MOU with WiSA Technologies to Integrate WiSA E into its HiFi ROSE Line of Media Streamers.
- Sweetgreen (SG) +21% Q1 earnings call release
- Array Technologies (ARRY) +18% Q1 earnings call release
- Natera (NTRA) +17% Q1 earnings call release
- Inseego (INSG) +15% Q1 earnings call release
- SoundHound (SOUN) +15% Q1 earnings call release
- Adma Biologics (ADMA) +14% Q1 earnings call release
- Guardant Health (GH) +13% Q1 earnings call release
- Victoria's Secret (VSCO) +12% sees adjusted profit for Q1, better-than-feared sales decline
- Ouster (OUST) +11% Q1 earnings call release
- TransCode Therapeutics (RNAZ) +8%.
- Standard Lithium (SLI) +8% Reports Fiscal Third Quarter 2024 Results, Schedules Investor Update Call
- Vivani Medical (VANI) +7%.
- Relay Therapeutics (RLAY) +7%.
- WaveDancer (WAVD) +7%.
- Mersana Therapeutics (MRSN) +7% Q1 earnings call release
- Mobile health Network (MNDR) +6% Network expands services to Malaysia.
- iHeartMedia (IHRT) +7% Q1 earnings call release
- Iamgold (IAG) +6% Q1 earnings call release
- D-Wave Quantum (QBTS) +5%.
More on premarkets gainers & stock
- D-Wave Quantum Inc. (QBTS) Q4 2023 Earnings Call Transcript
- D-Wave: Aiming To Leverage Zapata's Industrial Generative AI
- D-Wave Quantum reports mixed Q4 results; initiates Q1 and FY24 outlook
- D-Wave regains compliance with NYSE continued listing standards
- Seeking Alpha’s Quant Rating on D-Wave Quantum
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。